Discovering Deleterious Single Nucleotide Polymorphisms of Human AKT1 Oncogene: An In Silico Study.
Ruojun ZhangNahid AkhtarAtif Khurshid WaniKhalid RazaVikas KaushikPublished in: Life (Basel, Switzerland) (2023)
This study can be useful for pharmacogenomics, molecular diagnosis of diseases, and developing inhibitors of the AKT1 oncogene.